A method is described for the measurement of morphine in human plasma by ion-paired reverse-phase liquid chromatography. It includes a novel solid-phase extraction of morphine from plasma which is simple, rapid and complete. No known morphine metabolites could be shown to interfere with the measurements. Determination of morphine pharmacokinetics in patients undergoing heart surgery with 1 mglkg intravenous morphine produced plasma morphine clearances which agreed with established estimates.
The analgesic and psychological effects of poppy juice may have been known to the Sumerians some 6000 years ago. It was certainly known to Greek physicians, and the word opium is itself derived from the Greek name for the juice. Morphine, the main active opium alkaloid was isolated in Germany by Sertiirner in 1803, and the structure determined in 1925. Despite this long history, methods of measuring morphine in human or animal body fluids are relatively recent, dating from work by Way in the early 19605. 1 Morphine in plasma is particularly difficult to measure. Firstly, the molecule has low lipophilicity and simple solvent extraction methods are usually mcomplete.v ' Secondly, plasma concentrations after the usual parenteral doses of morphine are low and beyond the detection limit of common chromatographic methods. However, most of the difficulty is imposed by the extensive metabolism of morphine in rnamrnals.v 5 Morphine is mainly metabolised to the 3-0-glucuronide in both liver and gut wall; small amounts of morphine-S-glucuronide are also formed. Normorphine is produced by N-demethylation and may be a more important metabolite after oral than parenteral administration. The production of other metabolites has been suggested," but none are known to exist in human plasma in significant concentrations.
All of these factors impose special difficulties for the routine assay of morphine which do not use specialised techniques." Radioimmunoassay may be sufficiently sensitive and not require extraction, but the technique does suffer from major problems with cross-reaction with the numerous metabolites.i'" This paper reports a method using ion-paired reverse-phase liquid chromatography with electrochemical detection. It includes a novel method for the simple, rapid and complete extraction of morphine from human plasma. Morphine plasma concentrations and pharmacokinetics in patients undergoing cardiopulmonary bypass surgery are also described.
Methods

CHROMATOGRAPHY
A steel column (10 em x 4 mm internal diameter) together with a 2·5 em x 4 mm guard column was packed with octadecyl silica (ODS Hypersil, Shandon Southern Products, Cheshire) at a pressure of 6000 psi with an instantaneous column packer (Shandon Southern Products) using methanol as solvent. After packing, the solvent was changed to 25% acetonitrile for 1 hour. Thereafter, a flow rate of 1 mllmin was maintained through the column by an isocratic Altex 100A pump (Anachem Ltd, Luton, Bedfordshire) with a mobile phase consisting of: 30 ml 0·1 molll heptane sulphonic acid (Fisons Scientific Apparatus, Loughborough, Leicestershire) . Before use, the solvent was degassed under vacuum for several minutes, and then had pure nitrogen bubbled through a fine jet for about 5 minutes. The solvent was placed in a sealed reservoir in which air was displaced with nitrogen.
Samples were introduced into the solvent flow by means of a model 7125 Rheodyne injection port (Rheodyne Corp., Calif.) with either a 20 or a 50 III sample loop. Post-column measurement was with a model LCA15 electrochemical detector (EDT Research Ltd, London) with a glassy-carbon working electrode.
The electrode was set at +1 volt, with a sensitivity of 30 nanoamps. Changes in current were measured as peaks using a pen recorder; peak heights were measured using dividers and a millimeter scale.
SAMPLE EXTRACTION
Bacteriological glass tubes (62 x 10 mm) were siliconised with 2% dimethyldichlorosilane in 1,1,1-trichloroethane (BDH Chemicals, Poole). About 0·5 ml was pipetted into a tube, the inside coated with liquid and any remaining liquid aspirated away. The tubes were inverted and left to dry in air.
An octadecylsilyl Bond-Elute cartridge (Jones Chromatography, Glamorgan) was attached to a Vac-Elute separator (Jones Chromatography) and a vacuum applied. The cartridge was primed with 2 ml methanol followed by 2 ml of distilled water. The sample was prepared by adding 1 ml of 0·2 mol/l borate buffer, pH 9·0, and 0·2 ml of 0·1 mol/l heptane sulphonic acid to 1 ml of plasma and mixing in a vortex mixer for 5 seconds. The mixture was added to the top of the cartridge, and sucked through under reduced pressure. Distilled water (6 ml) was used to wash the cartridge, and when dry, the morphine was eluted with 2 ml methanol and the eluate collected into a siliconised glass tube. The methanol was evaporated under a stream of air at 65°C initially, and when about 1 ml remained final evaporation took place in a Buchler vortex-evaporator. The residue was reconstituted in 0·2 ml of mobile phase.
Morphine concentrations were expressed as nmol/l (1 nmol/l = 0·38 ng/ml morphine base); this was done to avoid the confusion which has arisen when authors have failed to specify whether morphine concentrations were morphine sulphate or morphine base. Morphine standards between 550 and 13 200 nmol/l were prepared by addition of morphine sulphate pentahydrate B.P. (Evans Medical, Greenford, Middlesex) to drug-free plasma; aqueous standards with the same concentrations were also prepared for recovery experiments. Control samples with weighed-in morphine concentrations of 660, 2640, 26400 and 66 000 nrnol/l in drug-free plasma were aliquoted and stored at -20°C. Standard morphine samples and controls were analysed with patient samples on every occasion. PATIENTS Ethical committee approval was obtained to study patients undergoing heart surgery. Four patients were premedicated with fentanyl, and 1 hour later anaesthesia was induced with thiopentone, fentanyl and pancuronium, followed by tracheal intubation and ventilation with nitrous oxide and oxygen (2:1). An intravenous dose of morphine sulphate pentahydrate (1 mg/kg) was given over 10 seconds. Samples were taken from the radial artery and collected into tubes containing lithium heparin anticoagulant before the dose of morphine, and at 1, 2, 3, 4, 5, 7·5, 10, 12,5, 15,20,30,40,60, 80, 100, 120, 140, 160, 180 and 240 minutes after the end of the injections. The samples were-centrifuged, the plasma separated off and stored at -20°C until analysed.
Plasma concentrations of individual patients were fitted to a sum of exponentials curve using a non-linear least squares program.l" the data was run as triexponential fits, and weighting was not used. The equation used was:
Kinetic parameters were then calculated from the fitted data.!' Half-life was calculated as of morphine, and a complete chromatogram could be obtained in less than 10 minutes. The retention time for morphine was 4 minutes; normorphine produced a similar detector response to morphine, but had a retention time of 3 minutes. No other morphine metabolite tested (including morphine-3-glucuronide) could be shown to produce a detector response. Several other opiates which had significant detector responses (metazinol, phenazocine, pentazocine, buprenorphine) had retention times in excess of 20 minutes in these chromatographic conditions. A standard curve for morphine in plasma is shown in Figure 2 . The equation of the regression line for this standard curve produced an intercept of 0·023 ± 0·03 (SEM) em and a correlation coefficient of 0·9999 with 14 sample points. The smallest concentration of morphine which could be detected in plasma under these conditions was 100 nmol/l; extraction of larger volumes of plasma and increased sensitivity of both detector and recorder reduced this detection limit to 10 nmol/l, Recovery of morphine in drug-free plasma, calculated by reference to aqueous standards of the same concentration, was in excess of 95% (Table 1) ; at 6600 nmol/l and below the recovery was essentially 100%. Precision was assessed using four frozen plasma morphine pools, each measured on 20 separate occasions; coefficients of variation were about 10% over a wide concentration range ( Table 2) . Plasma morphine concentrations after an intravenous bolus of 1 mg/kg for one patient are shown in Figure 3 ; the range of concentrations found after this dose of morphine was 200 to 20 000 nmol/l up to 240 minutes after the intravenous dose. Pharmacokinetic parameters calculated for four patients are given in Table 3 . Plasma morphine was added to drug-free plasma, aliquoted and stored frozen. Values were obtained from triexponential fits of individual plasma concentrations by non-linear least squares regression.
Discussion
It seems likely that oxidation of morphine at the electrochemical detector takes place at the phenolic oxygen at position 3. Slow oxidation of morphine in solution to the fluorescent dimer pseudomorphine can take place through this position, and some measurement methods depend on this reaction. I. 2. 12 Opiates with phenolic residues (buprenorphine, pentazocine, phenazocine, rneptazinol, nalorphine) all have electrochemical activity, in contrast to those which do not (Moore, Baldwin and Allen, unpublished observations). The main morphine metabolite morphine-3-glucuronide is blocked at the phenolic oxygen, and so will not react, unlike normorphine, which is as active as morphine under these conditions. This discriminating ability of the electrochemical detector immediately simplifies the analysis of morphine in body fluids.
The values for the three elimination half-lives calculated from triexponential fitting for. the four patients were in good agreement. The clearance of morphine from plasma ranged between 4·0 and 9·2 mU(min·kg body weight). The only known morphine metabolites which may then react on the detector are normorphine and morphine-6-glucuronide. Both are minor products; morphine-6-glucuronide is found in vanishingly small amounts (0,3% of an administered parenteral dose)." and no more than 5% of an oral dose may be converted to normorphine. The technique of ion-paired reverse-phase chromatography separated normorphine from morphine. No morphine-6glucuronide was available to test in this system, but because of the structural differences, it would be unlikely to co-extract and cochromatograph with morphine.
The use of ion-pairing to increase the apparent lipophilicity of morphine produced better chromatography than reverse phase alone.P and electrochemical detection offered a specific and sensitive method for measuring morphine. In addition, the retention of morphine by octadecylsilica in an ion-paired mode suggested a possible simplification of the usually tedious and inefficient solvent extraction methods. I, 2, 12, 13 The use of small disposable coarse-grained octadecylsilica columns did in fact provide a simple, rapid and efficient morphine extraction method which gave no interfering peaks on chromatography after extraction of drug-free plasma.
Use of the same fixed volume injection loop for all samples, standards and controls removed the necessity for internal standardisation. The only compound tested which chromatographed close to morphine was normorphine, which could not be used as an internal standard because of the possibility of interference from endogenous normorphine produced by metabolism. Other opiates which reacted on the electrochemical detector had very much greater retention times than morphine. However, the absence of an internal standard did not adversely affect the precision or accuracy of the method (Tables 1 and 2, Figure 2) .
The remaining problem, therefore, was one of sensitivity. In the method described here, morphine from 1 ml of plasma was concentrated in a final volume of 200 III before injection. A 50 III loop ensured that a minimum of 25 pmoles could be injected on to the column from a sample with a plasma concentration of 100 nmol/l, This provided adequate sensitivity over the plasma concentration range of 200-20000 nmol/l found in the patients studied.
Plasma morphine concentrations of 200 nmol/l are typically found about 3 hours after an intravenous injection of 10 mg morphine sulphate. For plasma concentrations below 200 nmol/l, use of larger sample volumes for extraction, an injection loop with greater volume, and higher sensitivity settings on both electrochemical detector and recorder could reduce the overall detection limit to a few nmol/l, as found by others.P Under these circumstances the precision need not deteriorate, 13 since the amount of drug actually analysed in each injection will not be dissimilar to that measured under standard conditions. To achieve this greater sensitivity, much more attention needs to be paid to solvent purity, for instance, and sample throughput may be low.
Plasma morphine concentrations and pharmacokinetics in patients undergoing cardiopulmonary bypass surgery have been reported in detail before,14 using a reportedly specific radioimmunoassay. As an additional means of establishing the validity of the method, patients undergoing similar surgery and given the same dose of morphine were examined. The plasma morphine concentrations are similar to those described by Stanski and his co-workers.l" However, a more sensitive indicator is the calculation of the plasma clearance of morphine, since it involves computation of the area under the plasma concentration against time curve, so summating any discrepancy. Total plasma morphine clearance in that study was in the range of 3·1-10·6 mV(min·kg), which encompasses the values obtained for all four patients studied here. Investigations in other groups of patients generally yield similar values for morphine plasma clearance'f using gasliquid chromatography with electron capture detectors.
The methods described here provide a rapid and complete extraction of morphine from human plasma. The discrimination of the electrochemical detector with ion-pair reversephase liquid chromatography enables morphine to be measured at low plasma concentrations without interference from the products of metabolism.
